Gritstone Oncology Inc (NASDAQ:GRTS)
| 6.31 Delayed Data As of 3:59pm ET |  -0.41 / -6.10%Today’s Change | 5.42 Today|||52-Week Range 12.96 | -29.65% Year-to-Date |
Latest GRTS News | Press Releases
No recent news for Gritstone Oncology Inc.
Today’s Trading
| Previous close | 6.72 |
| Today’s open | 6.69 |
| Day’s range | 6.30 - 6.70 |
| Volume | 24,501 |
| Average volume (3 months) | 222,025 |
| Market cap | $244.8M |
Data as of 3:59pm ET, 07/07/2020
Growth & Valuation
| Earnings growth (last year) | +61.25% |
| Earnings growth (this year) | +1.63% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +267.73% |
| P/E ratio | NM |
| Price/Sales | 68.95 |
| Price/Book | 1.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CASICASI Pharmaceuticals... | -0.20 | -8.10% |
| MNOVMediciNova Inc | -0.05 | -0.87% |
| MRNSMarinus Pharmaceutic... | -0.04 | -1.43% |
| RDHLRedhill Biopharma Lt... | +0.13 | +1.88% |
Data as of 3:59pm ET, 07/07/2020
Financials
| Next reporting date | August 17, 2020 |
| EPS forecast (this quarter) | -$0.72 |
| Annual revenue (last year) | $4.4M |
| Annual profit (last year) | -$94.4M |
| Net profit margin | -2,163.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
